Trans Genic Inc. (2342) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Trans Genic Inc.

Kidswell Bio Corp.

Cyfuse Biomedical KK

MEDINET Co., Ltd.

Oncolys BioPharma, Inc.

OncoTherapy Science, Inc.

StemCell Institute

Carna Biosciences, Inc.

Chiome Bioscience, Inc.

SUSMED, Inc.

Stella Pharma Corp.

Why is Trans Genic Inc. ?

Poor long term growth as Operating profit has grown by an annual rate -155.25% of over the last 5 years

With a growth in Net Profit of 6767.71%, the company declared Very Positive results in Mar 26

RAW MATERIAL COST(Y) Fallen by -20.66% (YoY)
DEBTORS TURNOVER RATIO(HY) Highest at 11.08 times
NET SALES(Q) Highest at JPY 3,479.2 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 16.85%, its profits have fallen by -63.7%

Underperformed the market in the last 1 year

The stock has generated a return of 16.85% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 85.12%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Trans Genic Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Trans Genic Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Trans Genic Inc.

16.85%

-0.11

93.56%

Japan Nikkei 225

88.41%

3.12

27.27%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.20%

EBIT Growth (5y)

-155.25%

EBIT to Interest (avg)

21.33

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.61

Tax Ratio

61.33%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

14.69%

ROE (avg)

10.01%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.97

EV to EBIT

-187.72

EV to EBITDA

39.41

EV to Capital Employed

0.97

EV to Sales

0.42

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.52%

ROE (Latest)

-6.29%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -20.66% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 11.08 times

NET SALES(Q)

Highest at JPY 3,479.2 MM

NET PROFIT(Q)

Highest at JPY 200.12 MM

-6What is not working for the Company

INTEREST(HY)

At JPY 19.31 MM has Grown at 6.34%

CASH AND EQV(HY)

Lowest at JPY 4,376.47 MM

Here's what is working for Trans Genic Inc.

Net Profit

At JPY 200.12 MM has Grown at 283.88%

over average net sales of the previous four periods of JPY -108.83 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (JPY MM)

Net Sales

Highest at JPY 3,479.2 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Net Profit

Highest at JPY 200.12 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Debtors Turnover Ratio

Highest at 11.08 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -20.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Trans Genic Inc.

Interest

At JPY 19.31 MM has Grown at 6.34%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv

Lowest at JPY 4,376.47 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents